Emil Chuang
Hoofd Techniek/Wetenschap/O&O bij Intrinsic Medicine, Inc.
Profiel
Emil Chuang is currently the Chief Medical Officer at Intrinsic Medicine, Inc. He previously held the same position at the same company.
Prior to that, he was the Global Head-Translational Research at Takeda Pharmaceutical Co., Ltd.
from 2016 to 2018.
From 2018 to 2020, he was the Vice President-Precision Medicine at Biora Therapeutics, Inc. Chuang completed his undergraduate degree at The University of Sydney.
Actieve functies van Emil Chuang
| Bedrijven | Functie | Begin |
|---|---|---|
Intrinsic Medicine, Inc.
 Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
Eerdere bekende functies van Emil Chuang
| Bedrijven | Functie | Einde |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2020 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01-06-2018 |
Opleiding van Emil Chuang
| The University of Sydney | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIORA THERAPEUTICS, INC. | Health Services |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Intrinsic Medicine, Inc.
Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Commercial Services |
